Company Filing History:
Years Active: 1985-1997
Title: The Innovations of John E McCullough
Introduction
John E McCullough is a notable inventor based in Whitehouse Station, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-fungal and antibacterial agents. With a total of 4 patents to his name, McCullough's work has had a meaningful impact on medical science.
Latest Patents
One of McCullough's latest patents is focused on the Fungal cell wall Protein CLY4, which includes the CLY4 gene, protein, vectors, and host cells. The gene product pCly4 plays a crucial role in fungal cell wall biosynthesis, making it a valuable target for the development of anti-fungal agents. Additionally, he has developed a novel antibiotic substance known as janthinocin, which is prepared through the cultivation of a strain of the microorganism Janthinobacterium lividum, ATCC No. 53,857. This innovation highlights his commitment to addressing pressing health challenges.
Career Highlights
Throughout his career, McCullough has worked with prominent companies such as E.R. Squibb & Sons, Inc. and Bristol-Myers Squibb Company. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Some of McCullough's notable coworkers include Joseph O'Sullivan and Adrienne A Tymiak. Their collaborative efforts have further advanced the research and development of innovative solutions in biotechnology.
Conclusion
John E McCullough's contributions to the field of biotechnology through his patents and collaborations demonstrate his dedication to innovation. His work continues to influence the development of new medical treatments and solutions.